Bone News and Research

RSS

$Early exposure to antacids could put infants at risk for bone fractures during childhood$

Early exposure to antacids could put infants at risk for bone fractures during childhood

Infants who are given antacids in their first year of life are more likely to fracture a bone later as a child, according to a new study published June 7 in Pediatrics.

11 Jun 2019

Study shows how SIRT1 plays key role in maintaining the regenerative potential of leukemic stem cells

Patients with chronic myeloid leukemia can be treated with tyrosine kinase inhibitors. While these effective drugs lead to deep remission and prolonged survival, primitive leukemia stem cells resist elimination during the remission and persist as a major barrier to cure.

11 Jun 2019

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

10 Jun 2019

Artificial intelligence can be used to efficiently diagnose rare diseases

Researchers at the University of Bonn show that using portrait photos in combination with genetic and patient data improves diagnoses.

6 Jun 2019

Nanotechnology treatment reverses multiple sclerosis symptoms in mice

A nanotechnology treatment derived from bone marrow stem cells has reversed multiple sclerosis symptoms in mice and could eventually be used to help humans, according to a new study led by University of California, Irvine researchers.

6 Jun 2019

Bioactive hydrogel promises faster wound healing

A new study published in the journal 'Science Advances' presents the use of a novel tissue engineering material composed of bioactive injectable hydrogel to speed up the rate of healing in wounded tissues.

6 Jun 2019

Scientists successfully carry out gene editing in vivo

Scientists at Harvard University have successfully proven that stem cells can be edited inside the body, rather than in a petri dish.

5 Jun 2019

Join Us For testXpo- International Forum for Materials Testing This Fall!

ZwickRoell is pleased to invite you to the premier event in materials testing for the medical and pharmaceutical industry. Join us this October 14-17 in Germany for the 28th international testXpo at ZwickRoell Headquarters in Ulm.

5 Jun 2019

Research on cannabis use in women limited, finds new study

A new study from the University of York shows that research into the association of psychosis with cannabis focuses almost completely on men users, significantly limiting our knowledge of the drug’s effects on human health.

5 Jun 2019

Cholesterol in eggs associated with cardiovascular disease and mortality

The risk of heart disease and death increases with the number of eggs an individual consumes, according to a UMass Lowell nutrition expert who has studied the issue.

4 Jun 2019

Researchers develop novel imaging test to predict immunotherapy response in kidney cancer

A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy.

4 Jun 2019

Study explores augmented ACL reconstruction procedure

An innovative procedure that explores the use of amnion, bone marrow concentrate and suture tape in anterior cruciate ligament reconstruction may result in earlier return to play protocols for athletes, suggests a new Marshall University study published in the May 6, 2019, edition of Arthroscopy Techniques, a companion to Arthroscopy: The Journal of Arthroscopic and Related Surgery.

4 Jun 2019

People living with HIV have increased risk for heart diseases and face health challenges

Effective antiretroviral therapy has changed the human immunodeficiency virus (HIV) from a progressive, fatal disease to a chronic, manageable condition that is associated with higher rates of heart attacks, strokes, heart failure, sudden cardiac deaths, and other diseases compared to people without HIV, according to a new scientific statement from the American Heart Association published in the Association journal Circulation.

3 Jun 2019

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer, according to a large study presented by Christopher Sweeney, MBBS of Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology, during the American Society of Clinical Oncology Annual Meeting.

3 Jun 2019

Blood stem cell breakthrough could spare some patients from side effects of cancer treatments

A method of growing blood stem cells in the laboratory has been developed by researchers at Stanford University and the University of Tokyo, in a breakthrough that could spare some people with blood and immune disorders from the side effects of intensive chemotherapy and radiotherapy.

31 May 2019

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.

31 May 2019

Study links heartburn drugs to fatal cases of heart, kidney disease and gastrointestinal cancer

Extended use of popular drugs to treat heartburn, ulcers and acid reflux has been associated with an increased risk of premature death. However, little has been known about the specific causes of death attributed to the drugs.

30 May 2019

Immune system discovery may lead to new models for diagnosing inflammatory diseases

A unique discovery about the nature of neutrophils -- the most numerous white blood cells in the body -- may lead to new models for diagnosing and tracking inflammatory diseases such as cancer and osteoarthritis.

30 May 2019

Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients

Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia, have been shown to be effective when given together for high-risk and older patients with the disease, according to a study at The University of Texas MD Anderson Cancer Center.

30 May 2019

Scientists move a step closer to developing targeted therapies for inflammatory diseases

Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.

30 May 2019

Bone News and Research

Early exposure to antacids could put infants at risk for bone fractures during childhood

Study shows how SIRT1 plays key role in maintaining the regenerative potential of leukemic stem cells

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Artificial intelligence can be used to efficiently diagnose rare diseases

Nanotechnology treatment reverses multiple sclerosis symptoms in mice

Bioactive hydrogel promises faster wound healing

Scientists successfully carry out gene editing in vivo

Join Us For testXpo- International Forum for Materials Testing This Fall!

Research on cannabis use in women limited, finds new study

Cholesterol in eggs associated with cardiovascular disease and mortality

Researchers develop novel imaging test to predict immunotherapy response in kidney cancer

Study explores augmented ACL reconstruction procedure

People living with HIV have increased risk for heart diseases and face health challenges

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Blood stem cell breakthrough could spare some patients from side effects of cancer treatments

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

Study links heartburn drugs to fatal cases of heart, kidney disease and gastrointestinal cancer

Immune system discovery may lead to new models for diagnosing inflammatory diseases

Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients

Scientists move a step closer to developing targeted therapies for inflammatory diseases

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News